Digital Innovation
Adding images to paid search ad copy – what does it mean for pharma?
Google Ads recently announced that pharmaceutical brands now have the option to include images in their paid search ads. While leveraging Google Ad Image Assets may increase engagement, the impact on audience quality and cost efficiencies is unknown and should be carefully tested. What are Paid Search Image Assets? Paid Search Image Assets allow advertisers … Continued
February 14, 2023
Digital Innovation
CTV Considerations for Pharma Brands
Traditional TV has played a dominant role in pharma marketing due to its power in reaching mass audiences. This dynamic has evolved substantially with people streaming content more than ever and advertisers following patients where they are. Here are some considerations when embarking into CTV and solidifying plans for 2023.
October 13, 2022
Digital Innovation
What is Connected TV, and what does it mean for Pharma Marketers?
Accelerated by the pandemic, TV consumption is changing and continues to decline due to fragmentation in the space. Traditional TV consumption on a single TV is quickly transitioning to increased on-demand streaming across multiple devices. Changing technology, paired with evolved TV watching, requires pharma marketers to modify their traditional approach to TV investment. Pharma has invested heavily in TV due to its reach capabilities, but now with Connected TV advertising (CTV), marketers can be even more savvy by reaching highly qualified audiences on TV more efficiently to drive brand impact.
April 25, 2022
Digital Health
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021
Digital Health
Realizing the Promise of Digital Health Partnerships
Why have commercial life sciences, with a track record of going it alone, pivoted to partnerships with the Digital Health Ecosystem? How might a life science marketer get their organization primed for more/better partnering? How is the success of a partnership measured? What are some of the key watchouts in partnering?
December 18, 2020
Digital Health
The Evolution of Social Determinants of Health during COVID-19
Social determinants of health (SDoH) are conditions in the places where people live, learn, work, and play that affect a wide range of health and quality-of life-risks and outcomes. You’ve probably seen or read the term in headlines, presented at conferences, or discussed at roundtables and meetings, but rarely mentioned in the coverage of SDoH is the pivotal role that pharma can play. Many leading pharmaceutical manufacturers have launched initiatives and partnerships aimed at addressing the impact of SDOH on health outcomes.
November 13, 2020
Digital Health
Social Determinants, The Causes of the Causes
The social determinants of health are the conditions in which people are born, grow, live, work and age.1 You’ve probably seen or read the term in headlines, presented at conferences, or discussed at roundtables and meeting, but how are social determinants of health (SDoH) relevant to pharma?
October 23, 2019
Digital Health
Finding the right partner: Pharma and Digital Health
Digital health is all the buzz these days, but how do you know which digital health opportunity is the best one to pursue for your brand or organization? Based on our experience working with our life science clients to partner and execute digital health programs, here are a few considerations for a successful partnership:
October 1, 2019